⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 8, 2015Clinical Transplantation

The inferior impact of antibody‐mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy

Kaiyin Wu Klemens Budde Danilo Schmidt Hans‐Hellmut Neumayer Lukas Lehner Jamal Bamoulid Birgit Rudolph

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The AMR+ TMA has inferior long-term graft survival, but grafts with sAMR+ TMA or dAMR+ TMA have similar characteristics and clinical courses.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2015) studied this question.

synapsesocial.com/papers/69d778caf44a16d01ef314a3 https://doi.org/10.1111/ctr.12645

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Thrombotic microangiopathy after kidney transplantationOriginal Research · 2006 · 100 citations
2Outcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal TransplantationRetrospective Study · 2003 · 94 citations
3De novo Thrombotic Microangiopathy in Renal Allograft Biopsies—Role of Antibody-Mediated RejectionRetrospective Study · 2010 · 115 citations
4Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney TransplantCohort Study · 2012 · 953 citations
5Cyclosporine withdrawal in post‐renal transplant thrombotic microangiopathyOriginal Research · 2005 · 11 citations
6Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial LesionsOriginal Research · 2014 · 1,349 citations
7Creatinine Reduction Ratio on Post-Transplant Day Two as Criterion in Defining Delayed Graft FunctionOriginal Research · 2004 · 116 citations
8The Morphology of “Acute Tubular Necrosis” in ManOriginal Research · 1979 · 458 citations
9Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung TransplantationClinical Transplantation · 2026
10Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and CareClinical Transplantation · 2026

More from Clinical Transplantation

More from Charité - Universitätsmedizin Berlin